Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca Pharma India MD Anandh Balasundaram resigns

Chief operating officer Jonathan Hunt will take over on an interim basis

The managing director of AstraZeneca's Indian subsidiary Anandh Balasundaram has resigned and will leave the company at the end of this week.

He has held the role since 2007, having previously spent two years as vice president of sales and marketing at Bangalore-based AstraZeneca Pharma India.

Balasundaram will be replaced on an interim basis by chief operating officer Jonathan Hunt, who will initially hold the role for four months, according to a filing made last week to the Bombay Stock Exchange.

28th August 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...